Mike Nolan

Freenome has hired Mike Nolan as its chief commercial officer. In his new position, Nolan will be responsible for bringing Freenome's first AI-generated, genomic cancer screening test, a blood test for colorectal cancer, to market. Most recently, Nolan was senior vice president of commercial operations at Foundation Medicine. Overall, he has more than 25 years of experience in strategic management and commercial leadership at companies such as Thermo Fisher Scientific, Life Technologies, Luminex, and Roche Diagnostics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.